Extrapulmonary tuberculosis

References

• World Health Organization. Global tuberculosis control report 2020. Geneva: World Health Organization; 2020.
   Google Scholar
• Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120(4):316–353.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Mohan A. Tuberculosis: from an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res. 2013;137:455.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Mohan A. Miliary tuberculosis. In: Schlossberg D, editor. Tuberculosis and nontuberculous mycobacterial infections. Sixth ed. Washington: ASM Press; 2017. p. 491–513.
   Google Scholar
• Sharma SK, Mohan A, Sharma A. Challenges in the diagnosis & treatment of miliary tuberculosis. Indian J Med Res. 2012;135(5):703–730.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Mohan A, Sharma A, et al. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis. 2005;5(7):415–430.
   PubMed Web of Science ®Google Scholar
• Central TB Division, Ministry of Health & Family Welfare, Government of India. National tuberculosis elimination programme annual report. India TB report 2020. New Delhi: Central TB Division, Ministry of Health & Family Welfare, Government of India; 2020.
   Google Scholar
• Thompson MM, Underwood MJ, Sayers RD, et al. Peripheral tuberculous lymphadenopathy: a review of 67 cases. Br J Surg. 1992;79:763–764.
   PubMed Web of Science ®Google Scholar
• Dandapat MC, Mishra BM, Dash SP, et al. Peripheral lymph node tuberculosis: a review of 80 cases. Br J Surg. 1990;77:911–912.
   PubMed Web of Science ®Google Scholar
• Subrahmanyam M. Role of surgery and chemotherapy for peripheral lymph node tuberculosis. Br J Surg. 1993;8:1547–1548.
   Google Scholar
• Fain O, Lortholary O, Djouab M, et al. Lymph node tuberculosis in the suburbs of Paris: 59 cases in adults not infected by the human immunodeficiency virus. Int J Tuberc Lung Dis. 1999;3(2):162–165.
   PubMed Web of Science ®Google Scholar
• Jones PG, Campbell PE. Tuberculous lymphadenitis in childhood: the significance of anonymous mycobacteria. Br J Surg. 1962;50:302–314.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Smith-Rohrberg D, Tahir M, et al. Radiological manifestations of splenic tuberculosis: a 23-patient case series from India. Indian J Med Res. 2007;125(5):669–678.
   PubMed Web of Science ®Google Scholar
• Rich AR, Mc Cordock HA. Pathogenesis of tuberculous meningitis. Bull John Hopkins Hosp. 1933;52:5–37.
   Google Scholar
• Medical Research Council. Streptomycin treatment of tuberculous meningitis: report of the committee on streptomycin in tuberculosis trials. Lancet. 1948;1(6503):582–597.
   PubMedGoogle Scholar
• Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA. 1979;241(3):264–268.
   PubMed Web of Science ®Google Scholar
• Mohan A, Thachil A, Sundar G, et al. Ventricular tachycardia and tuberculous lymphadenopathy: sign of myocardial tuberculosis? J Am Coll Cardiol. 2015;65(2):218–220.
   PubMed Web of Science ®Google Scholar
• Aggarwal AN, Agarwal R, Sehgal IS, et al. Adenosine deaminase for diagnosis of tuberculous pleural effusion: a systematic review and meta-analysis. PLoS One. 2019;14(3):e0213728.
   PubMed Web of Science ®Google Scholar
• Aggarwal AN, Agarwal R, Gupta D, et al. Interferon gamma release assays for diagnosis of pleural tuberculosis: a systematic review and meta-analysis. J Clin Microbiol. 2015;53(8):2451–2459.
   PubMed Web of Science ®Google Scholar
• Luo Y, Xue Y, Guo X, et al. Diagnostic value of pleural fluid T-SPOT for tuberculous pleurisy: an updated meta-analysis. Tuberculosis (Edinb). 2020;122:101941.
   PubMed Web of Science ®Google Scholar
• Tao L, Ning HJ, Nie HM, et al. Diagnostic value of adenosine deaminase in ascites for tuberculosis ascites: a meta-analysis. Diagn Microbiol Infect Dis. 2014;79(1):102–107.
   PubMed Web of Science ®Google Scholar
• Su SB, Qin SY, Guo XY, et al. Assessment by meta-analysis of interferon-gamma for the diagnosis of tuberculous peritonitis. World J Gastroenterol. 2013;19(10):1645–1651.
   PubMed Web of Science ®Google Scholar
• Luo Y, Xue Y, Mao L, et al. Diagnostic value of T-SPOT.TB assay for tuberculous peritonitis: a meta-analysis. Front Med (Lausanne). 2020;7:585180.
   PubMed Web of Science ®Google Scholar
• Xie DL, Cheng B, Sheng Y, et al. Diagnostic accuracy of adenosine deaminase for tuberculous pericarditis: a meta-analysis. Eur Rev Med Pharmacol Sci. 2015;19(22):4411–4418.
   PubMed Web of Science ®Google Scholar
• Liu C, Cui YL, Ding CM, et al. Diagnostic accuracy of interferon-gamma in pericardial effusions for tuberculous pericarditis: a meta-analysis. J Thorac Dis. 2018;10(2):854–860.
   PubMed Web of Science ®Google Scholar
• Hu X, Xing B, Wang W, et al. Diagnostic values of Xpert MTB/RIF, T-SPOT.TB and adenosine deaminase for HIV-negative tuberculous pericarditis in a high burden setting: a prospective observational study. Sci Rep. 2020;10(1):16325.
   PubMed Web of Science ®Google Scholar
• Pormohammad A, Riahi SM, Nasiri MJ, et al. Diagnostic test accuracy of adenosine deaminase for tuberculous meningitis: a systematic review and meta-analysis. J Infect. 2017;74(6):545–554.
   PubMed Web of Science ®Google Scholar
• Lu D, Chen C, Yu S, et al. Diagnosis of tuberculous meningitis using a combination of peripheral blood T-SPOT.TB and cerebrospinal fluid interferon-γ detection methods. Lab Med. 2016;47(1):6–12.
   PubMed Web of Science ®Google Scholar
• Luo Y, Xue Y, Guo X, et al. Diagnostic accuracy of T-SPOT.TB assay for tuberculous meningitis: an updated meta-analysis. Front Neurol. 2020;11:866.
   PubMed Web of Science ®Google Scholar
• Verma D, Soni G, Sharma R, et al. Diagnostic utility of fluorescent microscopy vis-a-vis GeneXpert MTB/RIF in extra pulmonary tuberculosis: a retrospective analysis. Natl J Lab Med. 2019;8:MO08–MO12.
   Google Scholar
• Metaferia Y, Seid A, Fenta GM, et al. Assessment of extrapulmonary tuberculosis using Gene Xpert MTB/RIF assay and fluorescent microscopy and its risk factors at Dessie referral hospital, Northeast Ethiopia. Biomed Res Int. 2018;2018:8207098.
   PubMed Web of Science ®Google Scholar
• Minion J, Pai M, Ramsay A, et al. Comparison of LED and conventional fluorescence microscopy for detection of acid fast bacilli in a low-incidence setting. PLoS One. 2011;6(7):e22495.
   PubMed Web of Science ®Google Scholar
• Steingart KR, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6(9):570–581.
   PubMed Web of Science ®Google Scholar
• Wang G, Yang X, Zhu J, et al. Evaluation of the efficacy of Myco/F lytic system, MGIT960 system and Lowenstein-Jensen medium for recovery of mycobacterium tuberculosis from sterile body fluids. Sci Rep. 2016;6(1):37757.
   PubMedGoogle Scholar
• Scarparo C, Piccoli P, Rigon A, et al. Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimens. Diagn Microbiol Infect Dis. 2002;44(2):157‐161.
   PubMed Web of Science ®Google Scholar
• Smaoui S, Kammoun S, Marouane C, et al. Evaluation of the BACTEC MGIT 960 TB with solid media for recovery of mycobacteria from extrapulmonary specimens in South Tunisia. J Med Diagn Meth. 2015;4:171.
   Google Scholar
• Purohit M, Mustafa T. Laboratory Diagnosis of extra-pulmonary tuberculosis (EPTB) in resource-constrained setting: state of the art, challenges and the need. J Clin Diagn Res. 2015;9(4):EE01–6.
   PubMed Web of Science ®Google Scholar
• Sanker P, Satheesan A, Ambika AP, et al. Role of line probe assay in detection of extra-pulmonary tuberculosis/multidrug-resistant tuberculosis: the experience from Kerala state, India. J Acad Clin Microbiol. 2017;19:12–18.
   Google Scholar
• Farooqui J, Qamar S, Ali I, et al. Utility of line probe assay for diagnosis of extrapulmonary tuberculosis. Int J Mycobacteriol. 2015;4:110.
   Google Scholar
• Niveditha G Study of burden, clinical characteristics, method of confirmation of diagnosis and treatment outcome in patients with extra-pulmonary tuberculosis. MD Thesis. Tirupati: Sri Venkateswara Institute of Medical Sciences; 2018.
   Google Scholar
• Rahul C Study of diagnostic accuracy of Xpert MTB/RIF in various forms of tuberculosis. MD Thesis. Tirupati: Sri Venkateswara Institute of Medical Sciences; 2019.
   Google Scholar
• Raju YS Unpublished data obtained via Personal communication. 2020
   Google Scholar
• Sharma SK, Kohli M, Chaubey J, et al. Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India. Eur Respir J. 2014;44(4):1090–1093.
   PubMed Web of Science ®Google Scholar
• Kohli M, Schiller I, Dendukuri N, et al. Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev. 2018;8:CD012768.
   Google Scholar
• Sharma SK, Ryan H, Khaparde S, et al. Index-TB guidelines: guidelines on extrapulmonary tuberculosis for India. Indian J Med Res. 2017;145(4):448–463.
   PubMedGoogle Scholar
• Wang F, Yu J, Zhou Y, et al. The use of TB-specific antigen/phytohemagglutinin ratio for diagnosis and treatment monitoring of extrapulmonary tuberculosis. Front Immunol. 2018;9:1047.
   PubMed Web of Science ®Google Scholar
• Sivakumar S, Chandramohan Y, Kathamuthu GR, et al. The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in South India. BMC Infect Dis. 2020 Nov 26;20(1):894.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Mohan A. Extrapulmonary tuberculosis. In: Hasnain SE, Ehtesham NZ, Grover S, editors. Mycobacterium tuberculosis: molecular infection biology, pathogenesis, diagnostics and new interventions. Singapore: Springer Nature Springer Pte Ltd; 2019. p. 37–53.
   Google Scholar
• Dheda K, Theron G, Calligaro G, et al. Drug-resistant tuberculosis. Sharma SK, Mohan A, editors. Textbook of tuberculosis and nontuberculous mycobacterial diseases. 3rd ed. New Delhi:Jaypee Brothers Medical Publishers; 2019. p.592–595.
   Google Scholar
• Central TB Division, Ministry of Health and Family Welfare, Government of India. Technical and operational guidelines for TB control in India. New Delhi: Central TB Division, Ministry of Health and Family Welfare, Government of India; 2016.
   Google Scholar
• Abulfathi AA, Decloedt EH, Svensson EM, et al. Clinical pharmacokinetics and pharmacodynamics of rifampicin in human tuberculosis. Clin Pharmacokinet. 2019;58(9):1103–1129.
   PubMed Web of Science ®Google Scholar
• Cresswell FV, Brake Te L, Atherton R, et al. Intensified antibiotic treatment of tuberculosis meningitis. Expert Rev Clin Pharmacol. 2019;12(3):267–288.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Treatment of tuberculosis: guidelines. WHO/HTM/TB/2009.420. 4th ed. Geneva: World Health Organization; 2010.
   Google Scholar
• World Health Organization. Treatment of tuberculosis. Guidelines for the treatment of drug-susceptible tuberculosis and patient care, 2017 update. WHO/HTM/TB/2017.05. Geneva: World Health Organization; 2017.
   Google Scholar
• Nahid P, Dorman SE, Alipanah N, et al. Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:e147–e195.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence, National Collaborating Centre for Chronic Conditions. 2016. NICE guideline (NG33) Published date: January 2016 Last updated: may 2016. [cited 2019 Mar 1]. Available from: https://www.nice.org.uk/guidance/ng33/resources/tuberculosis-1837390683589
   Google Scholar
• Ryan H, Yoo J, Darsini P. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev. 2017;3:CD001876.
   PubMedGoogle Scholar
• Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351(17):1741–1751.
   PubMed Web of Science ®Google Scholar
• Mayosi BM, Ntsekhe M, Bosch J, et al. Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis. N Engl J Med. 2014;371(12):1121–1130.
   PubMed Web of Science ®Google Scholar
• Geri G, Passeron A, Heym B, et al. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients. Infection. 2013;41(2):537–543.
   PubMed Web of Science ®Google Scholar
• Sarfaraz S, Iftikhar S, Salahuddin N. Frequency, clinical characteristics, risks, and outcomes of paradoxical upgrading reactions during anti-tuberculosis treatment in tuberculous lymphadenitis. Pak J Med Sci. 2020;36(1):S27–S32.
   PubMed Web of Science ®Google Scholar
• Meintjes G, Lawn SD, Scano F, et al. International network for the study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8(8):516–523.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Soneja M. HIV & immune reconstitution inflammatory syndrome (IRIS). Indian J Med Res. 2011;134(6):866–877.
   PubMed Web of Science ®Google Scholar
• Verma C, Sharma SK, Natarajan K, et al. Immunological alterations in tuberculosis associated immune reconstitution inflammatory syndrome in HIV infected patients. Indian J Experimental Biol. 2019;57:786–795.
   Web of Science ®Google Scholar
• Sharma SK, Dhooria S, Barwad P, et al. A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition. Indian J Med Res. 2010;131:804–808.
   PubMed Web of Science ®Google Scholar
• Blackmore TK, Manning L, Taylor WJ, et al. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis. 2008;47(10):e83–5.
   PubMed Web of Science ®Google Scholar
• Jorge J-H, Graciela C, Pablo A-P, et al. A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis. J Clin Rheumatol. 2012;18(4):189–191.
   PubMed Web of Science ®Google Scholar
• Molton JS, Huggan PJ, Archuleta S. Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction. Med J Aust. 2015;202(3):156–157.
   PubMed Web of Science ®Google Scholar
• Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the centers for disease control and prevention, the national institutes of health, and the HIV medicine association of the infectious diseases society of America. [cited 2020 May 18]. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf
   Google Scholar
• World Health Organization. WHO consolidated guidelines on tuberculosis, Module 4: treatment–drug resistant tuberculosis treatment June 2020. [cited 2020 Jul 1]. Available from: www.who.int/publications/i/item/9789240007048
   Google Scholar
• Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27-29 October 2020. Geneva: World Health Organization; 2021. CC BY-NC-SA 3.0 IGO.
   Google Scholar
• Wouda EMN, Stienstra Y, Van Der Werf TS, et al. Neurological and functional recovery in tuberculosis patients with spinal cord injury in the Netherlands. Neurorehabil. 2017;40(3):439–445.
   PubMed Web of Science ®Google Scholar